Funding

EpiFrontier Therapeutics

United States · Biotech · Healthtech

Develops novel therapies for beta globin disorders

Visit epifrontier.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Grant$32MJapan Agency for Medical Research and Development (AMED) — Role not disclosed

Investors

Japan Agency for Medical Research and Development (AMED)Grant

Coverage

Mar 24, 2026EpiFrontier Therapeutics · Grant

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesepifrontier.com ↗